(Q34758133)

Density-dependent dynamics and superinfection in an epidemic model.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

The prognostic value of the World Health Organisation staging system for HIV infection and disease in rural Uganda

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Simian immunodeficiency virus as a model of human HIV disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Global elimination of trachoma: how frequently should we administer mass chemotherapy?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Live attenuated SIV--a model of a vaccine for AIDS.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Predicting and preventing the emergence of antiviral drug resistance in HSV-2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

HIV vaccines--where are we going?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Emergence of drug resistance during an influenza epidemic: insights from a mathematical model

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

The incubation period of AIDS.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Natural history and spectrum of disease in adults with HIV/AIDS in Africa.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

To treat or not to treat: the case of tuberculosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Modelling HIV vaccination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Control strategies for tuberculosis epidemics: new models for old problems

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

The intrinsic transmission dynamics of tuberculosis epidemics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Drugs, sex and HIV : a mathematical model for New York City

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=30702

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

7 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Live-attenuated HIV vaccines: how safe is safe enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

A brief history of polio vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Protective immunity induced by live attenuated simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Imperfect vaccines and herd immunity to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

The dynamics of cocirculating influenza strains conferring partial cross-immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Optimal control of the chemotherapy of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Progress in the development of an HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Density-dependent dynamics and superinfection in an epidemic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Prospects for live attenuated HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Live attenuated AIDS vaccines: hazards and hopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998

Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.061029998